Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Saul N. Friedman, Malak Itani & Farrokh Dehdashti. (2021) PET Imaging for Gynecologic Malignancies. Radiologic Clinics of North America 59:5, pages 813-833.
Crossref
Crossref
Yuanyuan Jiang, Guozhu Hou, Fengyu Wu, Zhaohui Zhu, Wei Zhang & Wuying Cheng. (2020) The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment. Medicine 99:8, pages e19228.
Crossref
Crossref
Jukka Kemppainen, Johanna Hynninen, Johanna Virtanen & Marko Seppänen. (2019) PET/CT for Evaluation of Ovarian Cancer. Seminars in Nuclear Medicine 49:6, pages 484-492.
Crossref
Crossref
I. Thomassin-Naggara, E. Daraï, F. Lécuru & L. Fournier. (2019) Valeur diagnostique de l’imagerie (échographie, doppler, scanner, IRM et TEP-TDM) pour le diagnostic d’une masse ovarienne suspecte et le bilan d’extension d’un cancer de l’ovaire, des trompes ou péritonéal primitif. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa. Gynécologie Obstétrique Fertilité & Sénologie 47:2, pages 123-133.
Crossref
Crossref
C. Rousseau & P.Y. Salaün. (2019) Cancers de l’ovaire, du col utérin et de l’endomètre. Médecine Nucléaire 43:1, pages 104-124.
Crossref
Crossref
Joline F Roze, Jacob P Hoogendam, Fleur T van de Wetering, René Spijker, Leen Verleye, Joan Vlayen, Wouter B Veldhuis, Rob JPM Scholten & Ronald P Zweemer. (2018) Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. Cochrane Database of Systematic Reviews 2018:10.
Crossref
Crossref
Shuai Liu, Zheng Feng, Zhaoxia Jiang, Hao Wen, Junyan Xu, Herong Pan, Yu Deng, Lei Zhang, Xingzhu Ju, Xiaojun Chen & Xiaohua Wu. (2018) Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer. Nuclear Medicine Communications 39:10, pages 928-935.
Crossref
Crossref
Shuai Liu, Zheng Feng, Hao Wen, Zhaoxia Jiang, Herong Pan, Yu Deng, Lei Zhang, Xingzhu Ju, Xiaojun Chen & Xiaohua Wu. (2018) 18F-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value. Japanese Journal of Radiology 36:9, pages 544-550.
Crossref
Crossref
H. An, E.Y.P. Lee, K. Chiu & C. Chang. (2018) The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis. Clinical Radiology 73:7, pages 597-609.
Crossref
Crossref
Gigin Lin, Chyong-Huey Lai & Tzu-Chen Yen. (2018) Emerging Molecular Imaging Techniques in Gynecologic Oncology. PET Clinics 13:2, pages 289-299.
Crossref
Crossref
Rosj Gallicchio, Anna Nardelli, Angela Venetucci, Daniela Capacchione, Alessandra Pelagalli, Cesare Sirignano, Pierpaolo Mainenti, Piernicola Pedicini, Giuseppe Guglielmi & Giovanni Storto. (2017) F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer. European Journal of Radiology 93, pages 107-113.
Crossref
Crossref
B. González García, A.M. García Vicente, G.A. Jiménez Londoño, F.J. Pena Pardo, M.E. Bellón Guardia, M.P. Talavera Rubio, A. Palomar Muñoz, P. Gómez Herrero & Á.M. Soriano Castrejón. (2017) 18 F-FDG PET/CT as predictor of tumor biology and prognosis in epithelial ovarian carcinoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:4, pages 233-240.
Crossref
Crossref
B. González García, A.M. García Vicente, G.A. Jiménez Londoño, F.J. Pena Pardo, M.E. Bellón Guardia, M.P. Talavera Rubio, A. Palomar Muñoz, P. Gómez Herrero & Á.M. Soriano Castrejón. (2017) PET/TC con 18 F-FDG como predictor de la biología tumoral y del pronóstico en el cáncer epitelial ovárico. Revista Española de Medicina Nuclear e Imagen Molecular 36:4, pages 233-240.
Crossref
Crossref
Benjapa Khiewvan, Drew A. Torigian, Sahra Emamzadehfard, Koosha Paydary, Ali Salavati, Sina Houshmand, Thomas J. Werner & Abass Alavi. (2017) An update on the role of PET/CT and PET/MRI in ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging 44:6, pages 1079-1091.
Crossref
Crossref
Signe Frahm Bjørn, Tine Henrichsen Schnack, Henrik Lajer, Ib Jarle Christensen, Lene Lundvall, Lotte Nedergaard Thomsen & Claus Høgdall. (2017) Classification of Ovarian Cancer Surgery Facilitates Treatment Decisions in a Gynecological Multidisciplinary Team. International Journal of Gynecologic Cancer 27:2, pages 382-389.
Crossref
Crossref
Makoto Yamamoto, Tetsuya Tsujikawa, Yuko Fujita, Yoko Chino, Tetsuji Kurokawa, Yasushi Kiyono, Hidehiko Okazawa & Yoshio Yoshida. (2016) Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum‐based adjuvant chemotherapy. Cancer Science 107:4, pages 478-485.
Crossref
Crossref
Bhushan Desai & Hossein Jadvar. 2016. PET-CT. PET-CT
127
142
.
Hye Lim Park, Ie Ryung Yoo, Joo Hyun O, Eun Ji Han & Sung Hoon Kim. (2015) F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin. Journal of Cancer Research and Clinical Oncology 141:10, pages 1871-1878.
Crossref
Crossref
C M Nagle, S C Dixon, A Jensen, S K Kjaer, F Modugno, A deFazio, S Fereday, J Hung, S E Johnatty, P A Fasching, M W Beckmann, D Lambrechts, I Vergote, E Van Nieuwenhuysen, S Lambrechts, H A Risch, M A Rossing, J A Doherty, K G Wicklund, J Chang-Claude, M T Goodman, R B Ness, K Moysich, F Heitz, A du Bois, P Harter, I Schwaab, K Matsuo, S Hosono, E L Goode, R A Vierkant, M C Larson, B L Fridley, C Høgdall, J M Schildkraut, R P Weber, D W Cramer, K L Terry, E V Bandera, L Paddock, L Rodriguez-Rodriguez, N Wentzensen, H P Yang, L A Brinton, J Lissowska, E Høgdall, L Lundvall, A Whittemore, V McGuire, W Sieh, J Rothstein, R Sutphen, H Anton-Culver, A Ziogas, C L Pearce, A H Wu & P M Webb. (2015) Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer 113:5, pages 817-826.
Crossref
Crossref
Malene Grubbe Hildebrandt, Annette Raskov Kodahl, Dorte Teilmann-Jørgensen, Ole Mogensen & Pernille Tine Jensen. (2015) [18F]Fluorodeoxyglucose PET/Computed Tomography in Breast Cancer and Gynecologic Cancers. PET Clinics 10:1, pages 89-104.
Crossref
Crossref
C. Zwarthoed, J.-M. Bereder, P. Viau, C. Grangeon, F. Maurel, J. Darcourt, N. Mounier & M. Razzouk-Cadet. (2014) TEP au 18-FDG et carcinose péritonéale d’origine ovarienne : valeurs diagnostique et pronostique avant chimio-hyperthermie intra-péritonéale (CHIP). Médecine Nucléaire 38:6, pages 398-407.
Crossref
Crossref
Carsten Lindberg Fagö-Olsen, Bent Ottesen, Henrik Kehlet, Sofie Leisby Antonsen, Ib Jarle Christensen, Algirdas Markauskas, Berit Jul Mosgaard, Christian Ottosen, Charlotte Hasselholt Sogaard & Claus Hoegdall. (2014) Differences in Regional Diagnostic Strategies and in Intended Versus Actual First-Line Treatment of Patients With Advanced Ovarian Cancer in Denmark. International Journal of Gynecologic Cancer 24:7, pages 1195-1205.
Crossref
Crossref
Yuko Tanizaki, Aya Kobayashi, Michihisa Shiro, Nami Ota, Rei Takano, Yasushi Mabuchi, Shigetaka Yagi, Sawako Minami, Masaki Terada & Kazuhiko Ino. (2014) ATL. International Journal of Gynecologic Cancer 24:3, pages 454-460.
Crossref
Crossref
H. Dauwen, B. Van Calster, C.M. Deroose, K. Op de Beeck, F. Amant, P. Neven, P. Berteloot, K. Leunen, D. Timmerman & I. Vergote. (2013) PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer. Gynecologic Oncology 131:3, pages 694-700.
Crossref
Crossref
A. Fagotti, G. Vizzielli, F. Fanfani, B. Costantini, G. Ferrandina, V. Gallotta, S. Gueli Alletti, L. Tortorella & G. Scambia. (2013) Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience. Gynecologic Oncology 131:2, pages 341-346.
Crossref
Crossref
Seung-Hyuk Shim, Dae-Yeon Kim, Min-Jung Seo, Shin-Wha Lee, Jeong-Yeol Park, Jong Jin Lee, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim & Joo-Hyun Nam. (2013) Preoperative Fluorine 18 Fluorodeoxyglucose Tumoral Uptake Ratio Between Upper and Lower Abdomen in Primary Advanced-Stage Ovarian Cancer. International Journal of Gynecological Cancer 23:8, pages 1383-1392.
Crossref
Crossref
Jacqueline Brunetti. (2013) PET/CT in Gynecologic Malignancies. Radiologic Clinics of North America 51:5, pages 895-911.
Crossref
Crossref
Gretchen Glaser, Michelle Torres, Bohyun Kim, Giovanni Aletti, Amy Weaver, Andrea Mariani, Lynn Hartmann & William Cliby. (2013) The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer. Gynecologic Oncology 130:2, pages 280-283.
Crossref
Crossref
Carsten L. Fagö‐Olsen, Fanny Håkansson, Sofie L. Antonsen, Estrid Høgdall, Lene Lundvall, Lotte Nedergaard, Svend A. Engelholm & Claus Høgdall. (2013) Diagnostic accuracy of risk of malignancy index in predicting complete tumor removal at primary debulking surgery for ovarian cancer patients. Acta Obstetricia et Gynecologica Scandinavica 92:6, pages 721-726.
Crossref
Crossref
Hyun Hoon Chung, Hyun Woo Kwon, Keon Wook Kang, Noh-Hyun Park, Yong-Sang Song, June-Key Chung, Soon-Beom Kang & Jae Weon Kim. (2011) Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer. Annals of Surgical Oncology 19:6, pages 1966-1972.
Crossref
Crossref
V. Fiaschetti, F. Calabria, S. Crusco, A. Meschini, F. Nucera, O. Schillaci & G. Simonetti. (2011) MR-PET fusion imaging in evaluating adnexal lesions: a preliminary studyFusione RM/PET nelle lesioni annessiali: studio preliminare. La radiologia medica 116:8, pages 1288-1302.
Crossref
Crossref